News

Standard Chartered Adjusts Bitcoin and Ethereum Price Outlook

Standard Chartered Adjusts Bitcoin and Ethereum Price Outlook

Standard Chartered Adjusts 2026 Crypto Price Forecasts

Standard Chartered has recently revised its 2026 price predictions for Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) for a second time in just a few months. The adjustments reflect ongoing macroeconomic challenges and persistent outflows from exchange-traded funds (ETFs), which have contributed to the changing sentiment surrounding these cryptocurrencies.

Revised BTC and ETH Projections

The bank now anticipates Bitcoin will reach approximately $100,000 by the end of 2026, a significant drop from an earlier estimate of $150,000 and well beneath the previous ambitious target of $300,000. This forecast underscores the tempered expectations amid turbulent market conditions.

Potential Declines Ahead for Bitcoin

Industry analysts have suggested that Bitcoin could experience a further decline, potentially dipping to $50,000 as market weakness and continued ETF redemptions amplify uncertainties in investor sentiment. This prediction highlights the volatility inherent in the cryptocurrency market and the factors influencing price fluctuations.

Ethereum’s Target Cut

Similarly, Ethereum's 2026 target has been slashed to $4,000, down from $7,500. This steep reduction indicates the bank's cautious stance on Ethereum's recovery trajectory as the cryptocurrency battles its own set of challenges.

Market Dynamics and ETF Impact

Standard Chartered points out that Ethereum's price could retrace as low as $1,400 before a potential recovery begins. This observation, recently integrated into the bank's analysis, reflects broader market dynamics affecting both cryptocurrencies, with notable implications resulting from ETF market activities.

Vulnerabilities in the ETF Market

Over the last few months, Bitcoin has seen a more than 40% decline from its October peak, which was near $127,000. During this time frame, nearly $8 billion has exited U.S.-listed spot Bitcoin ETFs, raising concerns among investors. The declining ETF holdings, which have reduced by roughly 100,000 BTC from their peaks, point toward broader market challenges.

The Current Investment Landscape

As a result, the average ETF buyer currently finds themselves sitting on a cost basis of approximately $90,000, placing many in an unfavorable position. Standard Chartered's analyst Geoffrey Kendrick anticipates further capitulation in the market, given the recent softening of U.S. economic metrics and the likelihood of delayed Federal Reserve rate cuts, which could prolong uncertainty.

A Maturing Market Amidst Downturn

Despite the significant downturn, which has erased nearly $2 trillion from the overall crypto market, Kendrick argues that the current sell-off is displaying characteristics of a maturing asset class. The absence of major collapses of exchanges or trading platforms marks a notable difference from previous cycles, suggesting a more orderly market response.

As we navigate through these evolving narratives in the cryptocurrency space, it's essential for investors to stay informed and consider the implications of these revised forecasts on their investment strategies.

Frequently Asked Questions

Why did Standard Chartered lower Bitcoin and Ethereum price targets?

Standard Chartered adjusted its targets due to persistent macroeconomic headwinds and ongoing outflows from ETFs, affecting overall market sentiment.

What is the new price target for Bitcoin?

Bitcoin's revised price target for the end of 2026 is now set at $100,000, down from previous forecasts.

How low could Ethereum's price go according to the predictions?

Analysts suggest Ethereum could fall as low as $1,400 before it begins to recover.

What factors contribute to the decline in ETFs?

The decline in ETF holdings is linked to a significant drop in Bitcoin's price and broader market uncertainties, causing many investors to pull out funds.

Is the current cryptocurrency market more stable than before?

Yes, there's an argument for increased stability as the current sell-off has been orderly without major exchange collapses, indicating maturation of the market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Kinetiq Launches iHYPE with Hyperion DeFi's Groundbreaking Step

Updated Category News Views 224

Kinetiq Introduces iHYPE: A New Era for Institutions Kinetiq is thrilled to announce the launch of its innovative liquid staking product, iHYPE. This groundbreaking development comes with Hyperion DeFi, Inc. as its inaugural institutional depositor, creating a significant milestone in facilitating institutional access to Hyperliquid’s DeFi ecosystem. What is iHYPE?...

Continue Reading
Aclarion Partners with Advocate Health for Nociscan Trial

Updated Category News Views 112

Aclarion Partners with Advocate Health for Nociscan Trial Aclarion, Inc., a forward-thinking healthcare technology company, has taken a significant step in chronic low back pain research by partnering with Advocate Health. This collaboration involves the integration of Advocate Aurora Research Institute as a pivotal site for the CLARITY trial, aimed at validating the...

Continue Reading
BiomeNrich™ POST M005: Transforming Muscle Health Benefits

Updated Category News Views 346

Introducing BiomeNrich™ POST M005 for Muscle Health CJ BIO's BiomeNrich™ POST M005 stands as a remarkable advancement in nutritional science, recognized as the first Akkermansia muciniphila-based ingredient to receive New Dietary Ingredient Notification (NDIN) from the U.S. Food and Drug Administration (FDA). This achievement not only demonstrates the ingredient's...

Continue Reading
Exploring Emotional Intelligence for Enhanced Workplace Wellness

Updated Category News Views 95

Emotional Intelligence: A Transformative Force in Organizations In today’s world, the way leaders connect with their teams can greatly impact workplace dynamics. The University of Phoenix College of Doctoral Studies has shed light on a critical aspect of leadership through its newly published white paper titled "Emotional Intelligence as a Foundation for Organizational...

Continue Reading
How Consumer Trends Affect Refrigerated Shipping Demand Today

Updated Category News Views 183

Rising Demand for Refrigerated Transportation As consumers become more health-conscious and budget-aware, the trend of cooking at home is shifting market dynamics. This change has significantly increased the demand for refrigerated transportation, particularly in light of consumers purchasing their favorite fall staples. For instance, a surge in purchasing products such...

Continue Reading